Autres langues DexCom, Inc.

Actions

DXCM

US2521311074

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq 22:00:00 17/09/2026			Varia. 5j.	Varia. 1 janv.
87,93 ^USD	+0,68 %		+4,05 %	+32,48 %

17/09	DexCom, Inc. : Truist Securities favorable sur le dossier	ZM
16/09	Un initié de Dexcom a vendu des actions pour une valeur de 679 769 $, selon un récent dépôt auprès de la SEC	MT

Autres langues

16/09	Dexcom Insider Sold Shares Worth $679,769, According to a Recent SEC Filing
16/09	Valores destacados al cierre del mercado norteamericano
14/09	DexCom Promotes CFO Jereme Sylvain to Additional COO Role
14/09	Dexcom, Inc. Announces Appointment of Jereme Sylvain as Executive Vice President and Chief Operating Officer, Effective September 14, 2026
14/09	Dexcom Promotes Jereme Sylvain to Chief Operating Officer
14/09	Dexcom Insider Sold Shares Worth $302,936, According to a Recent SEC Filing
10/09	DexCom, Inc. Announces Appointment of Glenn S. Boehnlein as Director, Member of Operations & Innovation Committee and Audit Committee, Effective September 10, 2026
10/09	Dexcom Appoints Glenn Boehnlein to Board of Directors
01/09	Dexcom Announces Upcoming Conference Presentation
24/08	Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing
31/07	DexCom Shares Jump After Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised
31/07	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says
31/07	Afternoon meeting: Wall Street vuelve a comprar en las caídas
31/07	Wall Street's Dip Buyers Return
31/07	Analyst recommendations: Apple, Baxter International, Dexcom, Flex, Humana, Stellantis…
30/07	Tranche Update on DexCom, Inc.'s Equity Buyback Plan announced on May 15, 2026.
30/07	DexCom, Inc. Raises Earnings Guidance for the Fiscal Year 2026
30/07	DexCom Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance
30/07	Dexcom raises annual revenue forecast on strong demand for glucose monitors
30/07	(DXCM) DexCom Expects Full Year 2026 Revenue Range $5.18B - $5.25B, vs. FactSet Est of $5.22B
30/07	DexCom: Q2 Earnings Snapshot
30/07	Earnings Flash (DXCM) DexCom, Inc. Reports Q2 Revenue $1.31B, vs. FactSet Est of $1.29B
30/07	Earnings Flash (DXCM) DexCom, Inc. Posts Q2 Adjusted EPS $0.70 per Share, vs. FactSet Est of $0.61
30/07	Dexcom Reports Second Quarter 2026 Financial Results
30/07	DexCom, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026